Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.66 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.56 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.56 |
| ▸ | NPEPPS | P55786 | 7/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | ANPEP | P15144 | 7/20 | 0.51 |
| ▸ | SLC29A1 | Q99808 | 4/20 | 0.50 |
| ▸ | STAT6 | P42226 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31160178 | 0.86 | LMNA (0.79) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL29672354 | 0.85 | LMNA (0.64) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL29672348 | 0.85 | LMNA (0.64) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL17677178 | 0.85 | LMNA (0.64) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL20482906 | 0.85 | LMNA (0.64) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL29871247 | 0.84 | ADORA2A (0.54) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL26554333 | 0.84 | LMNA (0.59) | LMNAADORA2AADORA2BNPEPPSANPEP | |
| SCHEMBL5253091 | 0.83 | LMNA (0.58) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL16203604 | 0.83 | LMNA (0.62) | LMNAADORA2AADORA2BNPEPPSCYP1A2 | |
| SCHEMBL18512597 | 0.83 | LMNA (0.62) | LMNAADORA2AADORA2BNPEPPSCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118813612-A | Application of compound in RNAi (ribonucleic acid interference) medicament | 纳肽得(青岛)生物医药有限公司 | 2024-10-22 | — | — | CN | disclosed |